Yini okufanele uyenze uma ungehli isisindo emuthini we-GLP-1?
Okubalulekile, ukubekezela kubalulekile lapho uthatha umuthi we-GLP-1 njenge-semaglutide.
Ngokufanelekile, kuthatha okungenani amaviki ayi-12 ukubona imiphumela.
Nokho, uma ungaboni ukwehla kwesisindo ngaleso sikhathi noma unokukhathazeka, nazi ezinye izinketho ongazicabangela.
Khuluma nodokotela wakho
Ochwepheshe bagcizelela ukubaluleka kokuba nengxoxo nodokotela wakho, kungakhathaliseki ukuthi wehlisa isisindo noma cha.
Kubalulekile ukufuna isiqondiso kudokotela wakho, ongahlola izici ngazinye ezithinta ukusebenza kahle futhi ancome ukulungiswa okudingekayo, njengokushintsha umthamo noma ukuhlola ezinye izindlela zokwelapha.
Ochwepheshe bathi kufanele uhlangane nodokotela wakho okungenani kanye ngenyanga, kaningi lapho umthamo wesiguli sakho senyusiwe futhi uma siba nemiphumela emibi kakhulu.
Ukulungiswa kwendlela yokuphila
Imikhuba yokudla: Yeluleka iziguli ukuthi ziyeke ukudla lapho zisuthi, zidle kakhulu ukudla okungaphekiwe, okungacutshungulwanga, futhi ziziphekele ukudla kunokuthembela ekukhipheni noma ezinsizeni zokulethwa.
I-Hydration: Khuthaza iziguli ukuthi ziqinisekise ukuthi ziphuza amanzi anele nsuku zonke.
Ikhwalithi yokulala: Kunconywa ukuthi ulale amahora angu-7 kuya kwangu-8 ubusuku ngabunye ukuze usekele ukululama komzimba nokulawulwa kwesisindo.
Imikhuba Yokuzivocavoca: Gcizelela ukubaluleka kokuzivocavoca njalo ukuze ugcine impilo enhle futhi ukhuthaze ukulawula isisindo.
Izici ezingokomzwelo nezingokwengqondo: Veza ukuthi ukucindezeleka nezinkinga ezingokomzwelo zingathinta imikhuba yokudla kanye nekhwalithi yokulala, ngakho ukubhekana nalezi zinkinga kubalulekile ekuqhubekeleni phambili kwezempilo kanye nesisindo.
Phatha imiphumela emibi
Imiphumela emibi izonyamalala ngokuhamba kwesikhathi. Ochwepheshe bathi abantu bangathatha izinyathelo zokuzikhulula futhi bazilawule, okuhlanganisa:
Yidla ukudla okuncane futhi kaningi.
Gwema ukudla okunamafutha, okuhlala esiswini isikhathi eside futhi kungase kwenze izinkinga zesisu ezinjengokucanuzela kwenhliziyo ne-reflux zibe zimbi nakakhulu.
Khuluma nodokotela wakho mayelana nemithi etholakala ekhawunteni kanye nekadokotela engakusiza ukuthi wenze imiphumela engemihle ilawuleke, kodwa ingase ibe eyesikhashana.
Shintshela komunye umuthi
I-Semaglutide akuyona ukuphela kwendlela abantu abanayo. I-Telport yagunyazwa ngo-2023 ukwelapha ukukhuluphala nokukhuluphala ngokweqile kanye nezimo ezithile zezempilo ezingaphansi.
Ucwaningo lwango-2023 lwabonisa ukuthi abantu abakhuluphele ngokweqile noma abakhuluphele ngokweqile kodwa abangenaso isifo sikashukela balahlekelwa isilinganiso esingu-21% sesisindo somzimba wabo emasontweni angama-36.
I-Semaglutide, njenge-GLP-1 receptor agonist, ilingisa i-hormone ye-GLP-1, inciphisa isifiso sokudla ngokwandisa ukukhiqizwa kwe-insulin nokubonisa ukusutha ebuchosheni. Ngokuphambene, i-tepoxetine isebenza njenge-agonist ekabili ye-insulinotropic polypeptide (GIP) ethembele ku-glucose (GIP) kanye ne-GLP-1 receptors, ethuthukisa ukukhiqizwa kwe-insulin nokusutha. (Kokubili ama-agonists e-GIP kanye ne-GLP-1 angamahomoni akhiqizwa ngokwemvelo ohlelweni lwethu lwamathumbu.)
Ochwepheshe bathi abanye abantu bangase babe nemiphumela engcono yokulahlekelwa isisindo nge-tepoxetine, kuhlanganise nalabo abangaphenduli ku-semaglutide.
Isikhathi sokuthumela: Apr-18-2025